The Cochrane Library App presents the latest up-to-date evidence from the Cochrane Library in a convenient, easy to navigate format which provides you with relevant, accessible research, when you need it, from the world’s leading experts in evidence-informed health care.
All content in the app is free and new issues will download regularly.
Our monthly issues feature a hand-picked selection of Cochrane Systematic Reviews, specifically chosen by the Editor-in-chief. Abridged Cochrane Reviews provide the best possible tablet and phone reading experience and they are downloadable for reading offline. The Bookmark feature allows you to create your own special collection of Cochrane Reviews across issues. Additionally, the title page for every review includes a link to the full version of the review available on the Cochrane Library.
The Cochrane Reviews included in this month's issue focus on a diverse and interesting set of topics from recent publications, including preventing stunting in children from urban slums, antiretroviral therapy for HIV, reducing morbidity and mortality in malignant melanoma, androgen suppression therapy for prostate cancer, advocacy interventions for abused women, probiotics for acute otitis media in children, effects of inhaled corticosteroids on children’s growth, and lithium for acute mania.
Our main review this month is ‘Environmental interventions to reduce the consumption of sugar-sweetened beverages and their effects on health’. Frequent consumption of excess amounts of sugar‐sweetened beverages (SSB) is a risk factor for obesity, type 2 diabetes, cardiovascular disease and dental caries. Environmental interventions, i.e. interventions that alter the physical or social environment in which individuals make beverage choices, have been advocated to reduce the consumption of SSB. The authors from Cochrane Public Health Group assessed the effects of environmental interventions (excluding taxation) on the consumption of SSB and sugar‐sweetened milk, diet‐related anthropometric measures and health outcomes, and on any reported unintended consequences or adverse outcomes.